| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |